Dr. Reddy's (RDY) and GRA Announce Clinically Meaningful Data from Avigan Pivotal Studies

Go back to Dr. Reddy's (RDY) and GRA Announce Clinically Meaningful Data from Avigan Pivotal Studies

Dr. Reddys Labs (RDY) Reports Q3 EPS of $0.02

January 29, 2021 5:49 AM EST

Dr. Reddys Labs (NYSE: RDY) reported Q3 EPS of $0.02, versus ($0.47) reported last year. Revenue for the quarter came in at $675 million, versus $600 million reported last year.

Commenting on the results, Co-chairman & MD, G V Prasad said, We continued with our growth momentum while... More